Jing-Lan Hao

Jing-Lan Hao

Auto-generated profile, based on publicly available information

Jing-Lan Hao

College of Life Sciences, Shaanxi Normal University, Xi’an, China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 January 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
JYJuan Yang
Juan Yang
XLXiao Lu
Xiao Lu
JHJing-Lan Hao
Jing-Lan Hao
LLLan Li
Lan Li
YRYong-Tong Ruan
Yong-Tong Ruan
PGPing Gao
Ping Gao
Ferroptosis is a form of iron-dependent programmed cell death, which is distinct from apoptosis, necrosis, and autophagy. Mitochondria play a critical role in initiating and amplifying ferroptosis in cancer cells. Voltage-Dependent Anion Channel 1 (VDAC1) embedded in the mitochondrial outer membrane, exerts roles in regulation of ferroptosis. However, the mechanisms of VDAC1 oligomerization in regulating ferroptosis are not well elucidated. Here, we identify that a VDAC1 binding protein V-Set and Transmembrane Domain Containing 2 Like (VSTM2L), mainly localized to mitochondria, is positively associated with prostate cancer (PCa) progression, and a key regulator of ferroptosis. Moreover, VSTM2L knockdown in PCa cells enhances the sensitivity of RSL3-induced ferroptosis. Mechanistically, VSTM2L forms complex with VDAC1 and hexokinase 2 (HK2), enhancing their binding affinity and preventing VDAC1 oligomerization, thereby inhibiting ferroptosis and maintaining mitochondria homeostasis in vitro and in vivo. Collectively, our findings reveal a pivotal role for mitochondria-localized VSTM2L in driving ferroptosis resistance and highlight its potential as a ferroptosis-inducing therapeutic target for the treatment of PCa.

10 November 2021 in Frontiers in Oncology
Verified
Journal Article
Open access
XDXiaoming Dong
Xiaoming Dong
QZQin Zhang
Qin Zhang
JHJinglan Hao
Jinglan Hao
QXQianwen Xie
Qianwen Xie
BXBinbing Xu
Binbing Xu
PGPing Gao
Ping Gao
Aberrant telomerase reverse transcriptase (TERT) expression is crucial for tumor survival and cancer cells escaping apoptosis. Multiple TERT-locus variants at 5p15 have been discovered in association with cancer risk, yet the underlying mechanisms and clinical impacts remain unclear. Here, our association studies showed that the TERT promoter variant rs2853669 confers a risk of prostate cancer (PCa) in different ethnic groups. Further functional investigation revealed that the allele-specific binding of MYC and E2F1 at TERT promoter variant rs2853669 associates with elevated level of TERT in PCa. Mechanistically, androgen stimulations promoted the binding of MYC to allele T of rs2853669, thereby activating TERT, whereas hormone deprivations enhanced E2F1 binding at allele C of rs2853669, thus upregulating TERT expression. Notably, E2F1 could cooperate with AR signaling to regulate MYC expression. Clinical data demonstrated synergistic effects of MYC/E2F1/TERT expression or with the TT and CC genotype of rs2853669 on PCa prognosis and severity. Strikingly, single-nucleotide editing assays showed that the CC genotype of rs2853669 obviously promotes epithelial–mesenchymal transition (EMT) and the development of castration-resistant PCa (CRPC), confirmed by unbiased global transcriptome profiling. Our findings thus provided compelling evidence for understanding the roles of noncoding variations coordinated with androgen signaling and oncogenic transcription factors in mis-regulating TERT expression and driving PCa.

4 August 2025 in Oncogene
Verified
Journal Article
Closed access
JHJing-Lan Hao
Jing-Lan Hao
JHJia-Qi He
Jia-Qi He
HHHang Hu
Hang Hu
ZZZi-Heng Zhu
Zi-Heng Zhu
XZXi Zhao
Xi Zhao
XDXiao-Ming Dong
Xiao-Ming Dong

29 August 2024 in The FEBS Journal
Verified
Journal Article
Closed access
JHJinglan Hao
Jinglan Hao
GHGuiqin Han
Guiqin Han
XLXin Liang
Xin Liang
YRYongtong Ruan
Yongtong Ruan
CHChen Huang
Chen Huang
XDXiaoming Dong
Xiaoming Dong

31 October 2026 in Cell Death & Differentiation
Verified
Journal Article
Closed access
PDF file
JHJing-Lan Hao
Jing-Lan Hao
XLXin-Yi Luo
Xin-Yi Luo
ZZZi-Heng Zhu
Zi-Heng Zhu
XZXi Zhao
Xi Zhao
XHXian-Chao Huang
Xian-Chao Huang
PGPing Gao
Ping Gao

17 September 2026 in Oncogene
Verified
Journal Article
Closed access
PDF file
LLLan Li
Lan Li
XAXue-Ni An
Xue-Ni An
YRYong-Tong Ruan
Yong-Tong Ruan
RYRong Yang
Rong Yang
PLPeng Li
Peng Li
XDXiao-Ming Dong
Xiao-Ming Dong